Clorox® Fuzion® Cleaner Disinfectant Spray
Kill C. difficile spores in 2 minutes with this powerful, next-generation bleach. It delivers broad surface compatibility for everyday use and has a low odour that disappears in minutes.
Listed by the Australian Register of Therapeutic Goods (ARTG) for use against SARS-CoV-2 and COVID-19.
https://youtu.be/UBIfff-mdrU
Clorox® Fuzion® Cleaner Disinfectant Spray
Now you can use bleach in more places than ever before. This cleaner disinfectant delivers fast kill times with a neutralizer that breaks down the bleach to minimize residue and odour. Fuzion® uses a revolutionary technology to eliminate the chemical reaction that can damage surfaces and leave a residue. The solution contains sodium hypochlorite and a neutraliser that, when combined, form hypochlorous acid. The result is a highly effective disinfectant with broad surface compatibility and little to no residue. Fuzion® kills 53 microorganisms in two minutes or less, with a two-minute kill time on C. difficile spores.
• Kills C. diff in 2 Minutes: Hypochlorous acid solution is a strong oxidiser and highly effective surface disinfectant
• Broad Surface Compatibility: Safe for use on stainless steel, clear plastics, finished wood and many other common surfaces
• Low Residue: Leaves surfaces looking clean, not cloudy
• Low Odour: Mild odour dissipates in minutes
• Easy to Use: No PPE require
Listed by the Australian Register of Therapeutic Goods (ARTG) for use against SARS-CoV-2 and COVID-19.
Kill Table
BACTERIA | KILL TIME |
Acinetobacter baumannii (multidrug-resistant) | 1 min |
Bordetella pertussis | 1 min |
Burkholderia cepacia | 1 min |
Campylobacter jejuni | 1 min |
Enterobacter aerogenes | 1 min |
Enterobacter cloacae New Delhi Metallo-Beta-Lactamase 1 | 1 min |
Enterococcus faecalis | 1 min |
Enterococcus faecalis (vancomycin-resistant) (VRE) | 1 min |
Enterococcus faecium (multidrug-resistant) | 1 min |
Enterococcus hirae | 1 min |
Escherichia coli O157:H7 | 1 min |
Klebsiella pneumoniae (carbapenem-resistant) | 1 min |
Klebsiella pneumoniae New Delhi Metallo-Beta-Lactamase 1 | 1 min |
Legionella pneumophila | 1 min |
Listeria monocytogenes | 1 min |
Mycobacterium bovis (TB) | 1 min |
Proteus mirabilis | 1 min |
Pseudomonas aeruginosa | 1 min |
Salmonella enterica | 1 min |
Serratia marcescens | 1 min |
Shigella dysenteriae | 1 min |
Staphylococcus aureus | 1 min |
Staphylococcus aureus (multidrug-resistant) | 1 min |
Staphylococcus aureus (methicillin-resistant) (MRSA) | 1 min |
Staphylococcus aureus (vancomycin intermediate-resistant) (VISA) | 1 min |
Staphylococcus epidermidis (CoNS) | 1 min |
Stenotrophomonas maltophilia | 1 min |
Streptococcus pneumoniae | 1 min |
Streptococcus pneumoniae (multidrug-resistant) | 1 min |
Streptococcus pyogenes | 1 min |
VIRUS | KILL TIME |
Adenovirus Type 2 | 1 min |
Avian influenza A (H5N1) virus | 1 min |
Bovine viral diarrhea virus (surrogate for human hepatitis C virus) | 1 min |
Canine parvovirus | 1 min |
Enterovirus D68 | 1 min |
Hepatitis A virus (HAV) | 1 min |
Hepatitis B virus (HBV) | 1 min |
Herpes simplex virus type 1 (HSV-1) | 1 min |
Human coronavirus (RSV) | 1 min |
Human immunodeficiency virus type 1 (HIV-1) | 1 min |
Influenza A virus (H1N1) | 1 min |
Influenza B virus | 1 min |
Measles virus | 1 min |
Middle East respiratory syndrome coronavirus (MERS-CoV) | 1 min |
Norovirus | 1 min |
Respiratory syncytial virus (RSV) | 1 min |
Rhinovirus | 1 min |
Rotavirus | 1 min |
Severe acute respiratory syndrome-associated coronavirus (SARS-CoV) | 1 min |
FUNGI/VET | KILL TIME |
Candida albicans | 1 min |
Candida glabrata | 1 min |
Trichophyton mentagrophytes (athlete’s foot fungus) | 1 min |
SPORES | KILL TIME |
Clostridium difficile | 2 min |
1. Tierno, P. The Secret Life of Germs. New York, NY, USA: Atria Books, 2001. | |
2. Neely, AN. Persistence of Microorganisms on Common Hospital Surfaces: Strategies to Control Their Dissemination. Infection Control Resource Vol. 4, No. 4. | |
3. Kramer, A., Schwebke, I., Kampf, G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect. Dis. 2006, 6, 130. |